532999 Sigma-AldrichOrai1 Inhibitor, AnCoA4 - Calbiochem
AnCoA4 binds to the C-terminus region of Orai 1 and reduces its binding to STIM1 and blocks Ca2+ influx through the store operated calcium (SOC) channel (EC₅₀ = 880 nM).
More>> AnCoA4 binds to the C-terminus region of Orai 1 and reduces its binding to STIM1 and blocks Ca2+ influx through the store operated calcium (SOC) channel (EC₅₀ = 880 nM). Less<<Orai1 Inhibitor, AnCoA4 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: CRAC Inhibitor II
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| Empirical Formula |
|---|
| C₂₂H₁₈O₆ |
价格及供货情况
| 产品目录编号 | 库存情况 | 包装 | 数量 / 包装 | 价格 | 数量 | |
|---|---|---|---|---|---|---|
| 5.32999.0001 |
|
玻璃瓶 | 10 mg |
|
— |
| References | |
|---|---|
| References | Sadaghiani, A.M., et al. 2014. Chem. Biol. 21, 1278. |
| Product Information | |
|---|---|
| Form | Pale yellow solid |
| Hill Formula | C₂₂H₁₈O₆ |
| Chemical formula | C₂₂H₁₈O₆ |
| Reversible | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Orail1 |
| Purity | ≥96% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 5.32999.0001 | 04055977282023 |
Documentation
Orai1 Inhibitor, AnCoA4 - Calbiochem MSDS
| 职位 |
|---|
参考
| 参考信息概述 |
|---|
| Sadaghiani, A.M., et al. 2014. Chem. Biol. 21, 1278. |
小册子
| 标题 |
|---|
| Neuroscience Solutions for productive research |
技术信息
| 标题 |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |


